HomeMITPF • OTCMKTS
add
Mithra Pharmaceuticals Ord Shs
Previous close
$6.75
Year range
$6.75 - $6.75
Market cap
14.10M EUR
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 16.56M | -40.47% |
Operating expense | 22.18M | 6.12% |
Net income | -61.52M | -333.63% |
Net profit margin | -371.48 | -628.54% |
Earnings per share | — | — |
EBITDA | -9.35M | -352.66% |
Effective tax rate | -11.48% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.98M | -68.25% |
Total assets | 286.55M | -35.23% |
Total liabilities | 389.80M | -4.63% |
Total equity | -103.26M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -10.80% | — |
Return on capital | -15.31% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -61.52M | -333.63% |
Cash from operations | -8.21M | 30.48% |
Cash from investing | 545.50K | 108.16% |
Cash from financing | 295.50K | -98.36% |
Net change in cash | -7.37M | -1,353.06% |
Free cash flow | -3.04M | 43.62% |
About
Founded
1999
Website
Employees
270
